Vitamin D deficiency impairs antimicrobial peptide production, increasing susceptibility to streptococcal infections including pneumonia and meningitis.
LL-37 & lactoferrintwo key antimicrobial peptides directly stimulated by vitamin D to fight streptococcal bacteria
What the researchers found
The review connects three bodies of evidence. First, epidemiological data shows vitamin D deficiency is associated with higher risk of streptococcal infections, including pneumonia, meningitis, sepsis, and skin infections.
Second, vitamin D directly stimulates production of antimicrobial peptides, particularly cathelicidin (LL-37) and lactoferrin. These peptides punch holes in bacterial membranes and modulate immune cell behavior.
Third, vitamin D enhances other innate immune functions: phagocytosis (immune cells physically engulfing bacteria) and oxidative burst (production of reactive oxygen species that kill engulfed bacteria). Together, these mechanisms explain why low vitamin D leaves people more vulnerable to streptococcal infections.
Why it matters
Streptococcal infections kill hundreds of thousands of people annually, disproportionately in regions where vitamin D deficiency is common. Understanding how vitamin D supports antimicrobial peptide production could lead to simple, cheap interventions. Vitamin D supplementation costs pennies per day and could reduce infection risk in deficient populations.
The numbers in context
Cathelicidin and lactoferrin upregulated by vitamin D; deficiency common in low/middle-income countries
How the study worked
Narrative review of published epidemiological studies, in vitro experiments, animal models, and clinical data on the interaction between vitamin D, the immune system, and Streptococcus pathogens.
Who was studied
Review article (epidemiological and lab studies)
What this study cannot tell us
Most evidence linking vitamin D to streptococcal outcomes is observational. Observational studies cannot prove that vitamin D deficiency causes infections; other factors common in low-income settings (malnutrition, crowding, limited healthcare) also increase infection risk. Randomized supplementation trials specifically for streptococcal prevention are limited.
How to read the evidence
Moderate evidence. Strong biological plausibility supported by lab studies, but most human evidence linking vitamin D status to streptococcal outcomes is observational.
When this study was published
Published in 2020. Vitamin D and immune function research has continued with additional clinical trials since this review.
The bigger picture
Streptococcal infections kill hundreds of thousands annually, disproportionately in low-income countries where vitamin D deficiency is endemic. If vitamin D supplementation can boost antimicrobial peptide defenses, it could be a low-cost intervention to reduce this burden.
Questions still open
- Would vitamin D supplementation reduce streptococcal infection rates in deficient populations?
- Is there a minimum vitamin D level needed for adequate antimicrobial peptide production?
- Could vitamin D be used alongside antibiotics to improve treatment outcomes?
Common questions
Can taking vitamin D prevent infections?
What are antimicrobial peptides and why do they matter?
Read the original research
Vitamin D and Streptococci: The Interface of Nutrition, Host Immune Response, and Antimicrobial Activity in Response to Infection.
ACS infectious diseases, 6(12), 3131-3140
Citation
Guevara, Miriam A; Lu, Jacky; Moore, Rebecca E; Chambers, Schuyler A; Eastman, Alison J; Francis, Jamisha D; Noble, Kristen N; Doster, Ryan S; Osteen, Kevin G; Damo, Steven M; Manning, Shannon D; Aronoff, David M; Halasa, Natasha B; Townsend, Steven D; Gaddy, Jennifer A. (2020). Vitamin D and Streptococci: The Interface of Nutrition, Host Immune Response, and Antimicrobial Activity in Response to Infection.. ACS infectious diseases, 6(12), 3131-3140. https://doi.org/10.1021/acsinfecdis.0c00666